Hsiao D. Lieu - Oct 5, 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
SVP, Chief Medical Officer
Signature
/s/ Hsiao D. Lieu
Stock symbol
NGM
Transactions as of
Oct 5, 2021
Transactions value $
-$19,880
Form type
4
Date filed
10/7/2021, 08:04 PM
Previous filing
Aug 13, 2021
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Options Exercise $24.1K +2K $12.06* 2K Oct 5, 2021 Direct F1
transaction NGM Common Stock Sale -$44K -2K -100% $22.00* 0 Oct 5, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGM Stock Option (Right to Buy) Options Exercise $0 -2K -1.04% $0.00 190K Oct 5, 2021 Common Stock 2K $12.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2021.
F2 The shares subject to the stock option vest over a four-year period measured from the grant date, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.